Covington Capital Management’s GSK GSK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | $65K | Sell |
2,220
-200
| -8% | -$5.86K | ﹤0.01% | 522 |
|
|
2022
Q2 | $132K | Sell |
2,420
-23,262
| -91% | -$1.27M | 0.01% | 420 |
|
|
2022
Q1 | $904K | Buy |
25,682
+23,302
| +979% | +$820K | 0.03% | 246 |
|
|
2021
Q4 | $131K | Buy |
2,380
+820
| +53% | +$45.1K | ﹤0.01% | 409 |
|
|
2021
Q3 | $75K | Hold |
1,560
| – | – | ﹤0.01% | 486 |
|
|
2021
Q2 | $78K | Buy |
1,560
+160
| +11% | +$8K | ﹤0.01% | 478 |
|
|
2021
Q1 | $62K | Sell |
1,400
-120
| -8% | -$5.31K | ﹤0.01% | 451 |
|
|
2020
Q4 | $70K | Sell |
1,520
-120
| -7% | -$5.53K | ﹤0.01% | 431 |
|
|
2020
Q3 | $77K | Buy |
1,640
+40
| +3% | +$1.88K | ﹤0.01% | 407 |
|
|
2020
Q2 | $82K | Buy |
1,600
+120
| +8% | +$6.15K | ﹤0.01% | 390 |
|
|
2020
Q1 | $70K | Sell |
1,480
-240
| -14% | -$11.4K | ﹤0.01% | 377 |
|
|
2019
Q4 | $101K | Sell |
1,720
-16,880
| -91% | -$991K | 0.01% | 375 |
|
|
2019
Q3 | $679K | Buy |
18,600
+16,880
| +981% | +$616K | 0.04% | 210 |
|
|
2019
Q2 | $86K | Sell |
1,720
-16,840
| -91% | -$842K | 0.01% | 371 |
|
|
2019
Q1 | $662K | Buy |
18,560
+17,160
| +1,226% | +$612K | 0.04% | 199 |
|
|
2018
Q4 | $67K | Buy |
+1,400
| New | +$67K | ﹤0.01% | 383 |
|
|
2017
Q4 | – | Sell |
-620
| Closed | -$31K | – | 814 |
|
|
2017
Q3 | $31K | Buy |
+620
| New | +$31K | ﹤0.01% | 484 |
|